167 related articles for article (PubMed ID: 31324333)
1. [Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review].
Cherifi F; Rambeau A; Johnson A; Florescu C; Géry B; Babin E; Thariat J
Bull Cancer; 2019 Oct; 106(10):923-938. PubMed ID: 31324333
[TBL] [Abstract][Full Text] [Related]
2. [Molecular approaches to systemic therapy of adenoid cystic carcinoma of the head and neck area].
Büchsenschütz K; Veit JA; Schuler PJ; Thierauf J; Laban S; Fahimi F; Bankfalvi A; Lang S; Sauerwein W; Hoffmann TK
Laryngorhinootologie; 2014 Oct; 93(10):657-64. PubMed ID: 25302595
[TBL] [Abstract][Full Text] [Related]
3. [Systemic therapy strategies for head-neck carcinomas: current status].
Hoffmann TK
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S123-43. PubMed ID: 22456917
[TBL] [Abstract][Full Text] [Related]
4. [Molecularly targeted therapy in head and neck cancer].
Le Tourneau C
Bull Cancer; 2010 Dec; 97(12):1453-66. PubMed ID: 21134823
[TBL] [Abstract][Full Text] [Related]
5. [Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: A case-report and review of the literature].
Afani L; Errihani H; Benchafai I; Lalami Y
Cancer Radiother; 2016 Jul; 20(5):400-4. PubMed ID: 27131394
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
7. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
Laurie SA; Ho AL; Fury MG; Sherman E; Pfister DG
Lancet Oncol; 2011 Aug; 12(8):815-24. PubMed ID: 21147032
[TBL] [Abstract][Full Text] [Related]
8. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Ghosal N; Mais K; Shenjere P; Julyan P; Hastings D; Ward T; Ryder WD; Bruce I; Homer J; Slevin NJ
Br J Oral Maxillofac Surg; 2011 Oct; 49(7):510-5. PubMed ID: 21071117
[TBL] [Abstract][Full Text] [Related]
11. [Recent Developments Towards Molecularly Targeted Therapy of Head and Neck Cancer].
Strieth S; Ernst BP
Laryngorhinootologie; 2017 Mar; 96(3):185-198. PubMed ID: 28420025
[No Abstract] [Full Text] [Related]
12. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.
Papaspyrou G; Hoch S; Rinaldo A; Rodrigo JP; Takes RP; van Herpen C; Werner JA; Ferlito A
Head Neck; 2011 Jun; 33(6):905-11. PubMed ID: 20652885
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
14. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases.
Meyers M; Granger B; Herman P; Janot F; Garrel R; Fakhry N; Poissonnet G; Baujat B;
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):13-7. PubMed ID: 26493113
[TBL] [Abstract][Full Text] [Related]
15. Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
Lorini L; Ardighieri L; Bozzola A; Romani C; Bignotti E; Buglione M; Guerini A; Lombardi D; Deganello A; Tomasoni M; Bonini SA; Sigala S; Farina D; Ravanelli M; Bossi P
Oral Oncol; 2021 Apr; 115():105213. PubMed ID: 33578204
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapies for salivary gland adenoid cystic carcinoma.
Sahara S; Herzog AE; Nör JE
Am J Cancer Res; 2021; 11(9):4092-4110. PubMed ID: 34659878
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
Pfeffer MR; Talmi Y; Catane R; Symon Z; Yosepovitch A; Levitt M
Oral Oncol; 2007 Jan; 43(1):33-6. PubMed ID: 16757202
[TBL] [Abstract][Full Text] [Related]
18. Adenoid cystic carcinoma of the head and neck: a review.
Bradley PJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Apr; 12(2):127-32. PubMed ID: 15167050
[TBL] [Abstract][Full Text] [Related]
19. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
Azoury SC; Gilmore RC; Shukla V
Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
[TBL] [Abstract][Full Text] [Related]
20. [Rare tumors of the head and neck; on behalf of the REFCOR, the French Network of rare head and neck tumors].
Baujat B; Thariat J; Baglin AC; Costes V; Testelin S; Reyt E; Janot F;
Bull Cancer; 2014 May; 101(5):411-23. PubMed ID: 24886891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
